| Bisoprolol IMpurity |
比索洛尔杂质 |
2226263-67-6 |
| pranoprofen |
pranoprofen |
143436-36-6 |
| Etoricoxib Impurity M |
依托考昔杂质17 |
307531-95-9 |
| Neratinib dimethylamine N-oxide (M7) |
来那替尼二甲胺氮氧杂质 |
1376615-55-2 |
| Linagliptin Impurity C |
Linagliptin Impurity C |
1791405-13-4 |
| Etoricoxib impurity Q |
依托考昔杂质Q |
292067-97-1 |
| 2-Methyl-5-(3-(4-(Methylsulfonyl)phenyl)furan-2-yl)pyridine |
依托考昔杂质P |
307531-96-0 |
| (R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
曲格列汀杂质 |
1812193-01-3 |
| Dabigatran Etexilate iMpurity 1 |
达比加群酯杂质1 |
1610758-19-4 |
| Axitinib Impurity D |
阿西替尼杂质D |
1443118-72-6 |
| 4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-ol |
波齐替尼中间体 |
1429757-65-2 |
| Axitinib Impurity 4 |
阿西替尼杂质 4 |
1443118-73-7 |
| Ibrutinib Impurity 6 |
伊布替尼杂质6 |
1917333-91-5 |
| OseltaMivir iMpurity E |
奥司他韦杂质E |
903907-74-4 |
| Dabigatran Etexilate iMpurity 4 |
Dabigatran Etexilate iMpurity 4 |
1610758-21-8 |
| 1-(4-Bromophenyl)-2,2-bis(4-methoxyphenyl)-1-phenylethene |
1-(4-溴苯基)-2,2-二(4-甲氧基苯基)-1-苯乙烯 |
1378502-33-0 |
| Mirabegron iMpurity |
米拉贝隆杂质 |
1581285-26-8 |
| LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
左乙拉西坦杂质 |
1933471-30-7 |
| 2-((6-(3-aMinopiperidin-1-yl)-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)benzonitrile |
阿格列汀杂质A |
1108732-05-3 |
| Alogliptin Impurity C |
苯甲酸阿格列汀杂质G |
1108731-49-2 |
QQ
